MedTrace Logo

C-Reactive Protein as a Predictor of Stem Cell Transplant Complications

NCT00179868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-02-06

No results posted yet for this study

Summary

The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.

Conditions

Interventions

BEHAVIORAL

C-Reactive Protein levels

Each patient enrolled in the study will have a serum quantitative c-reactive protein (crp) level drawn on the day of transplant, day 7 of transplant, and twice weekly after that until recovery of neutrophil count (approximately 20-25 days). Patients will be followed for 100 days post-transplant for the development of the following complications: 1. Sepsis- defined as fever, positive blood culture, need for fluid resuscitation and/or pressor support. 2. Acute GVHD \> grade II defined according to the Seattle criteria 3. VOD- defined according to the modified Seattle criteria

Sponsors & Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Principal Investigators

  • Morris Kletzel, MD · Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility

Min Age
6 Months
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00179868 on ClinicalTrials.gov